Literature DB >> 21660524

Spontaneous remission in localized diffuse large B-cell lymphoma.

László Tamás1, Eszter Sári, Gábor Répássy, Péter Szabó, Eniko Bagdi, László Krenács, Judit Demeter.   

Abstract

Diffuse large B-cell lymphoma (DLBCL) is an aggressive neoplastic disease of the lymphatic system, the activated B-cell type of this disease is likely to have a substantially worse prognosis. In this study, we report the favorable outcome of the activated B-cell type of DLBCL, though untreated, 7 years after diagnosis. In 2003, DLBCL localized to the root of tongue was found in the patient complaining of dysphonia and a pharyngeal globus perception but the patient did not agree to get any active hematological treatment. During the following years, the patient did not have any complaints. At the otorhinolaryngological control examination, in 2010, she was complaint-free, had normal laboratory parameters. Moreover a PET-CT scan did not reveal metabolic activity relating to malignancy. The extraordinary disease process can be explained by the spontaneous regression of the activated B-cell type DLBCL. Spontaneous regression of oral lymphoma has been published only exceptionally. To our knowledge, no report of spontaneous regression of activated B-cell type DLBLC has been reported.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660524     DOI: 10.1007/s12253-011-9379-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

Review 1.  Spontaneous regression of cancer.

Authors:  R J Papac
Journal:  Cancer Treat Rev       Date:  1996-11       Impact factor: 12.111

2.  Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.

Authors:  Xiaoqing Lu; Hovav Nechushtan; Feiying Ding; Manuel F Rosado; Rakesh Singal; Ash A Alizadeh; Izidore S Lossos
Journal:  Blood       Date:  2004-12-09       Impact factor: 22.113

3.  Spontaneous regression of extranodal malignant lymphoma occurred in the gingiva.

Authors:  Makoto Koga; Jingo Kusukawa; Naofumi Hayabuchi
Journal:  Oral Oncol       Date:  2003-04       Impact factor: 5.337

Review 4.  Non-Hodgkin lymphoma.

Authors:  Linda S Evans; Barry W Hancock
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

Review 5.  Cancer immunoediting and "spontaneous" tumor regression.

Authors:  Neel Sengupta; Tammie S MacFie; Thomas T MacDonald; Daniel Pennington; Andrew R Silver
Journal:  Pathol Res Pract       Date:  2009-11-27       Impact factor: 3.250

Review 6.  Gene expression profiling in lymphoma diagnosis and management.

Authors:  Javeed Iqbal; Zhongfeng Liu; Karen Deffenbacher; Wing C Chan
Journal:  Best Pract Res Clin Haematol       Date:  2009-06       Impact factor: 3.020

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.

Authors:  Daniel O Persky; Joseph M Unger; Catherine M Spier; Baldassarre Stea; Michael LeBlanc; Matthew J McCarty; Lisa M Rimsza; Richard I Fisher; Thomas P Miller
Journal:  J Clin Oncol       Date:  2008-04-14       Impact factor: 44.544

9.  Spontaneous regression of non-Hodgkin's lymphoma: a report of nine cases.

Authors:  J G Krikorian; C S Portlock; P Cooney; S A Rosenberg
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

10.  Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.

Authors:  Katsuya Fujimoto; Tomoyuki Endo; Mitsufumi Nishio; Masato Obara; Keisuke Yamaguchi; Yukari Takeda; Hideki Goto; Ikumi Kasahara; Norihiro Sato; Takao Koike
Journal:  Int J Hematol       Date:  2009-10-06       Impact factor: 2.490

View more
  5 in total

1.  Spontaneous remission of epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly.

Authors:  T Mizuno; M Ishigaki; K Nakajima; T Matsue; M Fukushima; H Minato; N Nojima; Saito Atsushi; K Ishigami; H Atsumi; T Ito; M Iguchi; D Usuda; H Okamura; S Urashima; M Asano; A Fukuda; Y Izumi; N Takekoshi; T Kanda
Journal:  Case Rep Oncol       Date:  2013-05-15

2.  Comment: In Response to "Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation".

Authors:  Burak Uz; Kadir Acar
Journal:  Turk J Haematol       Date:  2016-04-18       Impact factor: 1.831

3.  Spontaneous remission in diffuse large cell lymphoma: a case report.

Authors:  J Snijder; N Mihyawi; A Frolov; A Ewton; G Rivero
Journal:  J Med Case Rep       Date:  2019-02-01

4.  Spontaneous resolution of untreated diffuse large B-cell lymphoma of maxillary bone after incisional biopsy.

Authors:  Lainey Flatow-Trujillo; Khine Win; Amy Jencks; Leslie Andritsos; Cecilia Arana Yi
Journal:  Clin Case Rep       Date:  2019-09-27

Review 5.  Case Report: Spontaneous Remission of an Infraorbital Follicular B-Cell Lymphoma: Case Report and Review of the Literature.

Authors:  Maxime Peeters; Joris Geusens; Fréderic Van der Cruyssen; Lucienne Michaux; Laurence de Leval; Thomas Tousseyn; Peter Vandenberghe; Constantinus Politis
Journal:  Pathol Oncol Res       Date:  2021-04-08       Impact factor: 3.201

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.